United Kingdom · Question · Written question
UIN 131326
Tixagevimab/cilgavimab
Introduced
28 February 2022
Last action
7 March 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
7 March 2022
Summary
To ask the Secretary of State for Health and Social Care, whether the UK intends to place an order of Evusheld in advance of its potential approval by the MHRA.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
28 February 2022
Written question
To ask the Secretary of State for Health and Social Care, whether the UK intends to place an order of Evusheld in advance of its potential approval by the MHRA.
Source: Commons
7 March 2022
Answer
Evusheld is not currently authorised for use in the United Kingdom. We are unable to provide information on negotiations with companies as this is commercially sensitive. Any public announcement would be made after an agreement is reached with companies.
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-02-28/131326
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1436574
- uk · wq-1436574 · source updated 7 March 2022